ALNY
Price
$331.91
Change
+$2.14 (+0.65%)
Updated
Jul 3 closing price
Capitalization
43.28B
25 days until earnings call
HALO
Price
$54.00
Change
+$0.16 (+0.30%)
Updated
Jul 3 closing price
Capitalization
6.65B
37 days until earnings call
Interact to see
Advertisement

ALNY vs HALO

Header iconALNY vs HALO Comparison
Open Charts ALNY vs HALOBanner chart's image
Alnylam Pharmaceuticals
Price$331.91
Change+$2.14 (+0.65%)
Volume$431.16K
Capitalization43.28B
Halozyme Therapeutics
Price$54.00
Change+$0.16 (+0.30%)
Volume$868.07K
Capitalization6.65B
ALNY vs HALO Comparison Chart in %
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALNY vs. HALO commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a Buy and HALO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (ALNY: $331.91 vs. HALO: $54.00)
Brand notoriety: ALNY and HALO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 46% vs. HALO: 29%
Market capitalization -- ALNY: $43.28B vs. HALO: $6.65B
ALNY [@Biotechnology] is valued at $43.28B. HALO’s [@Biotechnology] market capitalization is $6.65B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileHALO’s FA Score has 1 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • HALO’s FA Score: 1 green, 4 red.
According to our system of comparison, HALO is a better buy in the long-term than ALNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 4 TA indicator(s) are bullish while HALO’s TA Score has 3 bullish TA indicator(s).

  • ALNY’s TA Score: 4 bullish, 4 bearish.
  • HALO’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both ALNY and HALO are a good buy in the short-term.

Price Growth

ALNY (@Biotechnology) experienced а +4.29% price change this week, while HALO (@Biotechnology) price change was +2.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ALNY is expected to report earnings on Jul 31, 2025.

HALO is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($43.3B) has a higher market cap than HALO($6.65B). ALNY YTD gains are higher at: 41.052 vs. HALO (12.947). HALO has higher annual earnings (EBITDA): 705M vs. ALNY (-152.58M). ALNY has more cash in the bank: 2.63B vs. HALO (748M). ALNY has less debt than HALO: ALNY (1.3B) vs HALO (1.51B). ALNY has higher revenues than HALO: ALNY (2.35B) vs HALO (1.08B).
ALNYHALOALNY / HALO
Capitalization43.3B6.65B651%
EBITDA-152.58M705M-22%
Gain YTD41.05212.947317%
P/E RatioN/A14.36-
Revenue2.35B1.08B217%
Total Cash2.63B748M352%
Total Debt1.3B1.51B86%
FUNDAMENTALS RATINGS
ALNY vs HALO: Fundamental Ratings
ALNY
HALO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
1739
SMR RATING
1..100
10012
PRICE GROWTH RATING
1..100
4058
P/E GROWTH RATING
1..100
10090
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HALO's Valuation (75) in the Biotechnology industry is in the same range as ALNY (99). This means that HALO’s stock grew similarly to ALNY’s over the last 12 months.

ALNY's Profit vs Risk Rating (17) in the Biotechnology industry is in the same range as HALO (39). This means that ALNY’s stock grew similarly to HALO’s over the last 12 months.

HALO's SMR Rating (12) in the Biotechnology industry is significantly better than the same rating for ALNY (100). This means that HALO’s stock grew significantly faster than ALNY’s over the last 12 months.

ALNY's Price Growth Rating (40) in the Biotechnology industry is in the same range as HALO (58). This means that ALNY’s stock grew similarly to HALO’s over the last 12 months.

HALO's P/E Growth Rating (90) in the Biotechnology industry is in the same range as ALNY (100). This means that HALO’s stock grew similarly to ALNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALNYHALO
RSI
ODDS (%)
Bearish Trend 4 days ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 4 days ago
74%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
74%
MACD
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 5 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
71%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 11 days ago
66%
Bearish Trend 7 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SMDV67.770.38
+0.56%
ProShares Russell 2000 Dividend Growers
DFIV43.270.07
+0.16%
Dimensional International Value ETF
PSCQ27.70N/A
N/A
Pacer Swan SOS Conservative (Oct) ETF
PMJA25.75N/A
N/A
PGIM S&P 500 Max Buffer ETF - January
SGDJ50.58-0.13
-0.26%
Sprott Junior Gold Miners ETF

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
+0.65%
IONS - ALNY
58%
Loosely correlated
-1.35%
RARE - ALNY
42%
Loosely correlated
+1.14%
ARGX - ALNY
41%
Loosely correlated
-0.30%
TECH - ALNY
40%
Loosely correlated
-0.08%
CRNX - ALNY
38%
Loosely correlated
+1.22%
More

HALO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HALO has been loosely correlated with XENE. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HALO
1D Price
Change %
HALO100%
+0.30%
XENE - HALO
43%
Loosely correlated
-0.33%
VIR - HALO
40%
Loosely correlated
-0.37%
ARGX - HALO
37%
Loosely correlated
-0.30%
IMCR - HALO
33%
Poorly correlated
+0.82%
ALNY - HALO
32%
Poorly correlated
+0.65%
More